v


[Cutting-edge Appearance] SurgiBot® Robot Shines at EAU25, Demonstrating China's Innovative Strength

 

In March 2025, the 40th European Association of Urology Annual Congress (EAU25) grandly opened in Madrid, Spain. As the most influential academic event in the global field of urology, this year's EAU gathered top experts, medical institutions, and innovative enterprises from more than 100 countries to jointly discuss the latest cutting-edge progress in urology.

The SurgiBot® robot made a grand appearance with its self-developed serpentine-arm single-port surgical robot. Its breakthrough technological strength amazed the audience, showcasing the innovative achievements of China's high-end medical equipment to the world and becoming one of the most eye-catching surgical robot brands at this conference.

 

Technological Breakthrough: SurgiBot® Robot Sets the EAU25 Exhibition Site on Fire

In the EAU25 exhibition area, the SurgiBot® robot became the focus of attention. Its cutting-edge single-port minimally invasive surgical solution attracted nearly 500 international experts to stop by, visit, and experience the machine.

 

Revolutionary Breakthrough in Single-Port Surgery

The uniquely created serpentine-arm technology of the SurgiBot® robot, based on the bendable serpentine-arm technology, enables a SurgiBot single-port system to possess both the minimally invasive performance of a single-port and the large-range surgical capability (the size of a volleyball) of multiple ports. It replaces the current mainstream multi-port robots with more advanced minimally invasive technology.

A Broader Range of Motion
When extended, it can reach the size of a volleyball, providing an operating experience similar to that of multi-port endoscopes, reducing the learning curve, facilitating quick mastery, and meeting the need for rapid transitions during surgery.

More Stable Operating Ability
It provides an effective force load of up to 10N. The lifting of the robotic arm during surgery is stable and reliable, avoiding the risk of collision, which is beneficial for dealing with the challenges of complex surgeries.

More Definite Patient Benefits
Common urological surgeries, including extensive total ureterectomy, can be completed through a single small incision. At the same time, there is no need to extend the incision for specimen removal. Postoperative pain is reduced, and the recovery is fast.

A Wider Coverage of Indications
It can not only meet the application scenarios of common urological surgical procedures, including radical cystectomy, but also explore new minimally invasive surgical procedures for radical prostatectomy through transvesical approach and posterior approach, expanding the application boundaries of single-port robot technology.

 

Unanimous Recognition from Global Doctors, High Praise for Technological Leadership

Authoritative experts from various countries such as Spain, Germany, France, Italy, the United States, Japan, and South Korea have successively experienced the machine and highly praised the SurgiBot® robot for its precise control experience, clear imaging system, and excellent clinical application potential. They believe that the SurgiBot® robot has globally leading single-port minimally invasive surgical capabilities and is expected to become an important tool for future urological surgeries.

 

Increasing Heat of International Cooperation, Multiple Parties Seek In-depth Exchanges
In addition to gaining high recognition from doctors and the academic community, the SurgiBot® robot also attracted great interest from many industry partners at the exhibition site. Medical institutions, distribution channels, and industry experts from multiple countries came to communicate, hoping to further understand the technological advantages and market prospects of the SurgiBot® robot and discuss possible future cooperation. They look forward to introducing this leading single-port surgical robot technology into their domestic markets to contribute to the development and popularization of minimally invasive surgeries globally.

 

International Academic Focus, Promoting the Global Development of China's Single-Port Robot Surgery

At the EAU25 academic satellite meeting held at the same time, Professor Wu Zhenjie, an expert in urology from Changhai Hospital in Shanghai, gave a special report titled "Transpacific Robot-assisted Single-port Telesurgery in Live Porcine Models Expanding Surgical Frontiers". Professor Wu introduced in detail the innovative practice of the SurgiBot® robot in remote single-port robot surgery and shared the latest research achievements of the team in cross-border remote robot-assisted surgery, demonstrating China's technological innovation and breakthroughs in the fields of remote collaboration of surgical robots and minimally invasive surgery. The report triggered a heated discussion among the participating experts and inspired in-depth thinking about the future application and development of single-port robot technology.

 

Taking Advantage of EAU25, SurgiBot® Robot Accelerates Its Global Layout

EAU25 is not only an important platform for showcasing innovative technologies in urology but also a key opportunity to promote China's high-end medical equipment to the world. With the help of this conference, the SurgiBot® robot plans to launch multi-center clinical trials in Europe and plans to jointly build a training demonstration center with top European hospitals to promote the practical application of Chinese surgical robots in the international market.

In the future, the SurgiBot® robot will continue to focus on the field of single-port robot minimally invasive surgery, promote global cooperation, provide advanced minimally invasive surgical tools for more doctors, and bring more precise, safer, and minimally invasive surgical treatment options for patients around the world!

 

SurgiBot® Robot —— Stepping from EAU to the World
From EAU to the world, the SurgiBot® robot is reshaping the new pattern of surgical operations with innovative technology.
In the future, it will continue to deepen the strategy of "Made in China with Intelligence + Global Sharing", empower global healthcare with excellent single-port robot technology, and enable more patients to enjoy the benefits of precise minimally invasive surgery!

Important Notes

The Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has been approved by the National Medical Products Administration (NMPA) in China for urology and gynecology laparoscopic surgeries. Surgeons who wish to learn the surgical operations of the SHURUI robot should contact Beijing Surgerii Robotics Co., Ltd. to participate in the official training program. Patients who want to participate in the registered clinical trials of the SHURUI robot should contact the official cooperative hospitals of Surgerii and consult with surgeons to determine their suitability for surgery with the SHURUI robot. Both surgeons and patients should carefully understand all information regarding the performance of surgeries by the SHURUI robot and its potential risks.


Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other trademarks and may not be used without permission.